Adhesive World: May 2012
Covalon Technologies, an advanced medical technologies company, announced United States Food and Drug Administration ("FDA") approval of IV Clear™, a breakthrough antimicrobial silicone adhesive film dressing designed for securing vascular intravenous access devices. Covalon's IV Clear antimicrobial film dressings have a number of unique and highly desirable characteristics:
IV Clear is the only vascular access securement dressing approved by the FDA that combines the comfort of skin-friendly silicone adhesive technology with the advanced antimicrobial protection of two gold-standard antimicrobial agents - chlorhexidine and silver.
IV Clear has uniquely bonded the two antimicrobials into the actual adhesive of the soft and non-sensitizing silicone that allows the clear film dressing to comfortably secure vascular access devices to the skin while providing antimicrobial protection for up to 7 days.
"IV Clear is truly a new innovation in the fight against Catheter Related Blood Stream Infections (CRBSI), for which the Center for Disease Control (CDC) calls one of the most deadly and costly threats to patient safety," said Brian Pedlar, Covalon's Chief Executive Officer. With over 350 million IV catheter stabilization devices used in the United States alone and the adoption of antimicrobial securement devices experiencing double-digit growth, we fully expect IV Clear to be a strong competitor in the market." Covalon Technologies produces SilverCoatTM Antimicrobial Silicone Foley Catheter as well as IV Clear™ antimicrobial silicone adhesive film dressing.
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon was founded by a group of entrepreneurial PhD's from the University of Toronto who recognized an opportunity to serve the global community through the development of patented medical technology in the areas of infection control, advanced wound care and medical coatings. Covalon became a publically traded company in 2004 and successfully built partnerships with both small and large companies using a strategic business foundation based on advanced scientific and engineering know-how. Starting in 2010, Covalon added a management team with significant success in growing medical companies to help propel Covalon forward into a mature and well respected medical industry partner.